CONSENT, ACKNOWLEDGMENT AND AGREEMENTConsent, Acknowledgment and Agreement • March 13th, 2009 • Progenics Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS AGREEMENT (the “Agreement”) is entered into as of this 16th day of October, 2008, and is effective as of the Effective Date (as hereinafter defined), by and among Wyeth, acting through its Wyeth Pharmaceuticals Division, a corporation organized and existing under the laws of the State of Delaware and having a principal place of business at 500 Arcola Road, Collegeville, Pennsylvania 19426, Wyeth-Whitehall Pharmaceuticals, Inc., a corporation having a principal place of business at Road No. 3, Kilometer 142.1, Guayama, Puerto Rico 00784, and Wyeth-Ayerst Lederle, Inc., a corporation having a principal place of business at 65th Infantry Road, Kilometer 9.7, Carolina, Puerto Rico 00987-4904 (collectively “Wyeth”), Progenics Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware and having a principal place of business at 777 Old Saw Mill River Road, Tarrytown, NY 10591 (“Progenics”), and Ono Pharmaceutical Co., Ltd., a corporation existing
THIS AGREEMENT (the “Agreement”) is entered into as of this 16th day of October, 2008 and is effective as of the Effective Date (as hereinafter defined), by and among the University of Chicago, acting on behalf of itself and its affiliate ARCH...2008 Agreement Related to Progenics’ MNTX in-License • March 13th, 2009 • Progenics Pharmaceuticals Inc • Pharmaceutical preparations • New York
LICENSE AGREEMENT by and among ONO PHARMACEUTICAL CO., LTD. and PROGENICS PHARMACEUTICALS, INC. Dated as of October 16, 2008License Agreement • March 13th, 2009 • Progenics Pharmaceuticals Inc • Pharmaceutical preparations • New York
This LICENSE AGREEMENT (the “Agreement”) is made and entered into as of October 16, 2008 (the “Effective Date”), by and between Ono Pharmaceutical Co., Ltd., a corporation existing under the laws of Japan and having a place of business at 8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka 541-8564, Japan (“Ono”) and Progenics Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware and having a principal place of business at 777 Old Saw Mill River Road, Tarrytown, NY 10591 (“Progenics”). Ono and Progenics may each be referred to herein individually as a “Party” and, collectively, as the “Parties.”
PARTIAL TERMINATION AND LICENSE AGREEMENTPartial Termination and License Agreement • March 13th, 2009 • Progenics Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Partial Termination and License Agreement (the “Agreement”) is entered into this 16th day of October, 2008 (the “Effective Date”), by and among Wyeth, acting through its Wyeth Pharmaceuticals Division, a corporation organized and existing under the laws of the State of Delaware and having a principal place of business at 500 Arcola Road, Collegeville, Pennsylvania 19426, Wyeth-Whitehall Pharmaceuticals, Inc., a corporation having a principal place of business at Road No. 3, Kilometer 142.1, Guayama, Puerto Rico 00784, and Wyeth-Ayerst Lederle, Inc. a corporation having a principal place of business at 65th Infantry Road, Kilometer 9.7, Carolina, Puerto Rico 00987-4904 (collectively, “Wyeth”) and Progenics Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware and having a principal place of business at 777 Old Saw Mill River Road, Tarrytown, NY 10591 and Progenics Pharmaceuticals Nevada, Inc., a corporation organized and existing under
